November 19th, 2026First patient dosed in EMERALD trial of EO2002 for corneal edemaThe phase 2 EMERALD trial compares 2 doses of EO2002 with placebo, with a 15-letter BCVA gain at 26 weeks as the primary end point.Read more
November 19th, 2026High Point University optometry school earns ACOE preliminary approvalThe school will be admitting its inaugural Doctor of Optometry class in summer 2027, with full accreditation possible in 2030-31.Read more
November 18th, 2026Alice Epitropoulos, MD, on phentolamine for presbyopia treatmentThe FDA approved the Supplemental New Drug Application for phentolamine 0.75% (Ryzumvi, Opus Genetics/Viatris) to treat presbyopia.Read more
November 18th, 2026The Independent Advantage S02 E11: AI-powered front desks: Now and in the futureWill AI reinvent the way patients book appointments in the next 5 years? Raphael Rostenne weighs in in the season 2 finale of The Independent Advantage.Read more
November 17th, 2026Alberta expands optometry scope to include laser proceduresTrained Alberta optometrists may now perform SLT, peripheral iridotomy, and YAG capsulotomy in the office.Read more
November 16th, 2026When MEWDS doesn’t behave like MEWDS: A case studyIn this case of multiple evanescent white dot syndrome, a 20-year-old Hispanic woman first presented with new onset floaters in the left eye.Read more
November 14th, 2026Takeaways from this week in optometry: November 9-13For Veterans Day, this week’s recap spotlights veterans’ eye care, plus a GLP-1 label change and VR perimetry for glaucoma.Read more
November 13th, 2026Nicholas Garn, OD, on opening an OD-owned surgery suite in IndianaIn this Q&A, Nicholas Garn, OD, discusses surgeon contracts, cost planning, and sharing surgical time at his OD-owned suite in Indiana.Read more